Senseonics Holdings, Inc.

Contributing Author

Recent Articles by Senseonics Holdings, Inc.

May-07	Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results SENS -6.16% SENS GlobeNewswire
May-04	Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares SENS GlobeNewswire
May-04	Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million SENS GlobeNewswire
May-01	Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern Time SENS -22.84% GlobeNewswire
Apr-30	Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants SENS -22.84% GlobeNewswire
Apr-30	Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants SENS -22.84% SENS GlobeNewswire
Apr-24	Senseonics Announces European Launch of Eversense 365, The World's First and Only One Year CGM System SENS GlobeNewswire
Mar-14	First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear SENS GlobeNewswire
Mar-02	Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results SENS -18.07% SENS GlobeNewswire
Feb-19	Sequel Med Tech and Senseonics Launch Transformative Combination of twiist and Eversense 365 SENS GlobeNewswire
Jan-29	Senseonics Receives European Approval for Eversense 365, World's Longest-lasting Continuous Glucose Monitor SENS +5.32% SENS GlobeNewswire
Jan-28	Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference SENS -7.21% GlobeNewswire
Jan-12	Senseonics Announces Preliminary Unaudited Revenue for Fourth Quarter 2025 and Provides Business Update SENS GlobeNewswire
Jan-08	Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist Automated Insulin Delivery (AID) System SENS +8.04% GlobeNewswire
Nov-10	Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference SENS +5.32% GlobeNewswire
Nov-10	Senseonics Announces Transfer to Nasdaq Stock Exchange SENS +5.32% GlobeNewswire
Nov-05	Senseonics Holdings, Inc. Reports Third Quarter Financial Results SENS -7.58% SENS GlobeNewswire
Oct-22	Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time SENS -9.17% SENS +6.06% GlobeNewswire
Oct-06	Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update SENS +22.03% SENS -16.92% GlobeNewswire
Sep-03	Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365 SENS GlobeNewswire
Aug-06	Senseonics Holdings, Inc. Reports Second Quarter Financial Results SENS GlobeNewswire
Jul-16	Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time SENS +5.07% GlobeNewswire
Jun-04	Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense 365 Continuous Glucose Monitoring System for People with Diabetes SENS GlobeNewswire
May-21	Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement SENS -5.57% GlobeNewswire
May-15	Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement SENS GlobeNewswire
May-15	Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement SENS -5.11% GlobeNewswire
May-08	Senseonics Holdings, Inc. Reports First Quarter Financial Results SENS -15.17% SENS +6.78% GlobeNewswire

Senseonics Holdings, Inc.

Recent Articles by Senseonics Holdings, Inc.

Upgrade your Finviz experience